CPDC has collaborated with Lab2Market (L2M) to launch the L2M Discover Radiopharma program, a groundbreaking initiative to cultivate entrepreneurial skills among Canadian researchers in the radiopharmaceutical sector. Beginning on September 16, 2025, the 10-week virtual training program will equip students and faculty with the foundational tools necessary to embark on their entrepreneurial journey and advance their research toward commercialization. Tailored specifically for researchers in the radiopharmaceutical field, this program aims to bridge the gap between scientific discovery and market impact by cultivating entrepreneurial mindsets and skillsets. With a long-standing relationship with CPDC, McMaster University is the strategic delivery partner for L2M Discover Radiopharma and is well-positioned to lead this program

Starting September 16, 2025, the program offers:

• Expert-led sessions tailored to the radiopharmaceutical industry
• Mentorship opportunities
• Access to a national network of entrepreneurs and experts

Participants will explore how to translate their research into real-world impact and commercial opportunities.

Applications are open until September 3, 2025.